How Long Between Mounjaro Doses: What the Evidence Says

The licensed interval between Mounjaro doses is exactly seven days, no shorter, with specific guidance for doses taken late.
Each Mounjaro KwikPen contains four weekly doses; the day of the week you choose for injection becomes your fixed 'Mounjaro day'.
If a dose is missed and fewer than four days have passed, take it as soon as you remember; if more than four days have passed, skip it and resume on your usual day.
Dose timing decisions, including changes to your schedule, should always be confirmed with your prescriber, not adjusted independently.

Mounjaro (tirzepatide) is taken once every seven days. That fixed weekly interval is established in the licensed dosing schedule and reflected in the clinical trial data that formed the basis of NICE's recommendation of tirzepatide for weight management. Missing that interval — in either direction — has practical consequences, and understanding why the timing matters is as important as knowing what it is. These are prescription-only medicines assessed by a clinician before they are prescribed; the guidance below covers the factual framework, but your prescriber's advice always takes precedence.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Timing Rules Behind Mounjaro's Weekly Schedule, and What Happens When They Slip

Why seven days? The science behind the fixed interval

The seven-day interval is not arbitrary. Tirzepatide has a half-life of approximately five days in the body, which means it is still active and accumulating in the early weeks of treatment. The once-weekly schedule was designed around this pharmacokinetic profile to maintain steady circulating levels, enough to sustain appetite suppression and slow gastric emptying between doses, without sharp peaks and troughs that could amplify side effects.

In SURMOUNT-1, the pivotal phase 3 trial published in the New England Journal of Medicine, participants who received tirzepatide on this weekly schedule achieved average body-weight reductions of around 20–21% at 15 mg over 72 weeks. That consistency of effect depended on adherence to the weekly rhythm. Drifting the interval (taking two doses too close together or letting a significant gap develop) disrupts the steady-state concentration the schedule is built to maintain. The NHS Mounjaro medicines page confirms the once-weekly regimen as standard and is the first port of call for patients wanting the plain-English version of the dosing framework.

It is also worth knowing that tirzepatide carries a Black Triangle (▼) designation from the MHRA, meaning it is under additional post-market surveillance. That context shapes why the licensed schedule is followed precisely, rather than adapted informally.

What 'seven days' looks like in practice, and how far is too far

Pick a day that genuinely suits your week and keep it. Many people find a weekday morning works well, it means any mild nausea from a new dose or a dose increase tends to fall on days when a normal routine provides distraction. If Monday morning before work is your anchor, that is your injection day, every week.

If you want to shift your injection day (say, to avoid a holiday or an occasion where you know you will be far from a fridge) you can move the dose forward or back, but only so that the gap stays at least four days and does not exceed ten days. Moving it further in either direction is outside what the licensed guidance supports. The question of how long you can leave between Mounjaro doses before a missed dose becomes a skipped one is a practical one; the four-day / ten-day rules from the Summary of Product Characteristics are the reference points your prescriber will use.

When a dose is missed, the rule from the SmPC published on the electronic Medicines Compendium is straightforward: if fewer than four days remain before your next scheduled dose, leave it and resume on your normal day. Taking two doses within four days of each other risks amplifying gastrointestinal side effects and is not supported by the clinical evidence. Some people find it helpful to think of the minimum days between Mounjaro doses as a hard floor, not a suggestion.

Starting doses, step-ups, and the timing that matters most

The Mounjaro titration schedule begins at 2.5 mg, a dose whose purpose is to let the body acclimatise, not to drive weight loss. The licensed schedule moves through 5 mg, 7.5 mg, 10 mg, 12.5 mg and up to 15 mg, with each step separated by approximately four weeks at the current dose. Those four-week gaps are themselves a timing question: the difference between 2.5 mg and 5 mg Mounjaro is not just strength, it marks the transition from a tolerability phase to a therapeutic one, and stepping up too quickly is one of the more common reasons people find side effects harder to manage.

At nume, every dose increase is clinically reviewed before it is dispensed. Your prescriber confirms that you have had enough time at the current dose, checks for any concerns, and only then approves the next pen. This is not a formality. The same prescriber who reviewed your original consultation reviews your progress, a real clinician, reading your responses, not a software filter processing a form.

If you are looking at the broader Mounjaro dose schedule and wondering which strength you might reach, that is a conversation shaped by how your body responds, not by a fixed timeline anyone can predict in advance. What can be said with confidence is that the weekly interval between individual injections stays constant throughout, 2.5 mg, 5 mg or 15 mg, the seven-day gap does not change.

Practical details worth knowing before your first pen

Mounjaro pens are stored in the fridge at 2–8°C. Each pen contains four doses (one month's supply) and should be kept refrigerated until you need it. For the specific room-temperature window (relevant if you are travelling or the pen has been out of the fridge), the Patient Information Leaflet is the definitive source; never rely on a figure quoted online, including here, because storage guidance can be version-specific.

Injection sites rotate between the abdomen, upper thigh and upper arm; using the same site repeatedly can affect absorption. For people new to self-injection, what to expect at 5 mg (the first active therapeutic dose) is often the question that matters most in the early weeks. Technique, timing, storage and side-effect management all interact, and the aftercare support available through a regulated service makes a material difference to how well the weekly schedule is sustained.

The cost of Mounjaro through a private pharmacy is a separate consideration for many people, particularly those comparing NHS eligibility against the private route. If you have questions about how treatment is structured at nume (sorry, at about us) the team is available seven days a week. For anyone ready to take the next step, starting a free consultation is how the clinical review begins.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions